US Patent 7439230 Methods of treatment using CTLA4 mutant molecules
Patent 7439230 was granted and assigned to Bristol-Myers Squibb on October, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7439230 Methods of treatment using CTLA4 mutant molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
